The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking: A randomized, controlled trial
Sponsor: |
NIAAA |
Enrolling: |
Male and Female Patients |
Study Length: |
12 Weeks |
IRB Number: |
7889 |
U.S. Govt. ID: |
NCT04084860 |
Contact: |
HOPE Clinic: 646-854-9395 / hopeclinic@nyspi.columbia.edu |
This 12-week free and confidential outpatient research study is recruiting healthy adults who are currently seeking treatment for alcohol use. Participants will engage in twice-weekly clinic visits during which they will meet with a physician and complete measures with research assistants. Participants will also receive innovative, investigative medications twice throughout this trial (Weeks2 and 5) to help facilitate their engagement in treatment. Upon completion of the study, participants will be referred to appropriate community providers to ensure that they have the necessary means to continue their progress.
This study is closed
Investigator
Elias Dakwar, MD
Is alcohol a problem for you? |
Yes |
No |
Are you seeking treatment for your alcohol use? |
Yes |
No |